Everyone knows that faster and cheaper genome sequencing is ushering in a new era of healthcare. What many people don’t fully realize, however, is how the confluence of “big biology” with “big data” is opening huge opportunities for innovative tech startups and established players alike—in areas from next-generation sequencing to data acquisition, storage, distribution, analysis, and more.

With its expertise in high-performance computing, predictive analytics, and software development, coupled with its leadership in genomics, brain science, biotechnology, and digital health, San Diego is uniquely poised to be a leader in this data-biology confluence.

Please join Xconomy San Diego for a half-day forum that will highlight the prospects—and challenges—facing technology innovators on both the big data and big biology sides of this equation.